Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study

Gefitinib-Integrated Regimen versus Chemotherapy Alone in Heavily Pretreated Patients with Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Case-Control Study

BACKGROUND: The study aimed to compare the tolerability and efficacy of gefitinib combined with chemotherapy agents versus chemotherapy alone for the treatment of epidermal growth factor receptor (EGFR)–mutated lung adenocarcinoma in heavily pretreated patients. METHODS: The study was designed as a...

Full description

Bibliographic Details
Main Authors: Nan-Jie Zhao, Zhao Sun, Yuzhou Wang, Xiaohong Ning, Ning Jia, Changting Meng, Yingyi Wang
Format: Article
Language:English
Published: Elsevier 2014-08-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523314000606

Internet

http://www.sciencedirect.com/science/article/pii/S1936523314000606

Similar Items